| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |